[Biology and therapy of hairy cell leukemia]. 1993

T Robak
II Klinika ChorĂ³b Wewnetrznych AM, Lodzi.

In the paper recent advances in etiology and pathogenesis of hairy cell leukaemia (HCL) are reviewed. Role of human T-cell leukaemia virus II (HTLV-II) and Epstein-Barr virus as well as benzene and other environmental factors in the etiology of this leukaemia is presented. The new achievements in diagnosis including electron microscopic, cytogenetic and immunologic studies are discussed. A rare variants of HCL are described. The special attention is paid to the modern approach in treatment including alfa-interferon, 2'-deoxycoformycin and 2-chlorodeoxyadenosine.

UI MeSH Term Description Entries
D007943 Leukemia, Hairy Cell A neoplastic disease of the lymphoreticular cells which is considered to be a rare type of chronic leukemia; it is characterized by an insidious onset, splenomegaly, anemia, granulocytopenia, thrombocytopenia, little or no lymphadenopathy, and the presence of "hairy" or "flagellated" cells in the blood and bone marrow. Hairy Cell Leukemia,Leukemic Reticuloendotheliosis,Reticuloendotheliosis, Leukemic,Hairy Cell Leukemias,Leukemias, Hairy Cell,Leukemic Reticuloendothelioses,Reticuloendothelioses, Leukemic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015490 HTLV-I Infections Diseases caused by HUMAN T-LYMPHOTROPIC VIRUS 1. Human T-lymphotropic Virus 1 Infection,Human T-lymphotropic Virus 1 Infections,Infections, HTLV-I,HTLV I Infections,HTLV-I Infection,Human T lymphotropic Virus 1 Infection,Human T lymphotropic Virus 1 Infections,Infection, HTLV-I,Infections, HTLV I
D015491 HTLV-II Infections Diseases caused by HUMAN T-LYMPHOTROPIC VIRUS 2. Human T-lymphotropic Virus 2 Infection,Human T-lymphotropic Virus 2 Infections,Infections, HTLV-II,HTLV-II Infection,Human T lymphotropic Virus 2 Infection,Human T lymphotropic Virus 2 Infections,Infection, HTLV-II,Infections, HTLV II

Related Publications

T Robak
July 1986, Seminars in hematology,
T Robak
October 2009, Leukemia & lymphoma,
T Robak
April 2020, Current treatment options in oncology,
T Robak
July 2021, International journal of molecular sciences,
T Robak
August 1982, The New England journal of medicine,
T Robak
January 1993, Cancer treatment and research,
T Robak
October 2018, JAMA,
T Robak
October 1990, Deutsche medizinische Wochenschrift (1946),
T Robak
February 1987, Cancer,
T Robak
December 1984, Seminars in oncology,
Copied contents to your clipboard!